Edition:
United Kingdom

Eleven Biotherapeutics Inc (EBIO.OQ)

EBIO.OQ on NASDAQ Stock Exchange Global Market

0.68USD
15 Dec 2017
Change (% chg)

$0.02 (+3.12%)
Prev Close
$0.66
Open
$0.65
Day's High
$0.72
Day's Low
$0.65
Volume
215,291
Avg. Vol
106,815
52-wk High
$2.53
52-wk Low
$0.63

Select another date:

Mon, Nov 20 2017

BRIEF-Eleven Biotherapeutics reports Q3 loss per share $0.37

* Eleven Biotherapeutics reports third quarter 2017 financial results

BRIEF-Eleven Biotherapeutics files for non timely 10-Q

* Eleven biotherapeutics inc files for non timely 10-Q - Sec Filing‍​ Source text: (http://bit.ly/2zZDGkA) Further company coverage:

BRIEF-Eleven Biotherapeutics CFO steps down; Richard Fitzgerald named interim CFO

* Eleven Biotherapeutics appoints Richard Fitzgerald as interim chief financial officer

BRIEF-Eleven Biotherapeutics ‍appoints Richard Fitzgerald as interim CFO

* Eleven Biotherapeutics Inc - ‍appointed Richard F. Fitzgerald, age 54, as company's interim Chief Financial Officer, effective October 13, 2017​

BRIEF-Eleven Biotherapeutics files for offering of $12.5 mln common stock

* Eleven biotherapeutics inc- files for offering of $12.5 million common stock Source text for Eikon: (http://bit.ly/2y1EGTF) Further company coverage:

BRIEF-Eleven Biotherapeutics Q2 loss per share $0.30

* Eleven Biotherapeutics reports second quarter 2017 financial results

Select another date: